ASP Isotopes (ASPI) Osake Kurssi

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Washington, Washington Dc and currently employs 46 full-time employees. The company went IPO on 2022-11-10. The firm has a license to use technology, the Aerodynamic Separation Process (ASP technology), originally developed and licensed to it by Klydon Proprietary Ltd (Klydon), for the production, distribution, marketing and sale of all isotopes. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Molybdenum-100 (Mo-100) and Silicon-28 (Si-28). The company also intends to develop the ASP technology to produce enriched Uranium-235 (U-235). The company operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for highly specialized end markets; Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market, and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the license agreement with Klydon.